Stem cell therapy for Rod and Cone Dystrophy in Uk

Dystrophy stems from genetic mutations, with ongoing research identifying around 35 genes responsible for affecting the cone photoreceptor cells within the retina. These changes lead to the gradual degeneration of these cells, resulting in the progressive loss of vision. Collectively, these conditions affect an estimated 1 in 20,000 to 100,000 individuals worldwide. Eye injuries are broadly categorized into minor and major types. Minor injuries may result from exposure to dust, soap, smoke, etc., while major injuries typically occur due to accidents involving the eye.

Providing patients with the best available treatments, remedies, and medicines is crucial. The eyes are integral to our daily life and cognitive processes; therefore, maintaining their health is essential. While curing Rod dystrophy may be challenging or impossible, ongoing efforts are indispensable. It remains the responsibility of healthcare providers to exhaust every effort to restore vision or explore treatments aimed at enhancing visual capabilities. Stem cell therapy for Rod and Cone Dystrophy in the UK helps you in curing this problem.

Rod and Cone Dystrophy treatment:

Stem cell therapy for Rod and Cone Dystrophy provides advanced facilities that offer promising treatments for Rod and Cone conditions, alleviating the need to seek treatment abroad. These facilities prioritize cutting-edge technology and maintain strict hygiene standards, ensuring patients receive optimal care.

Rod and Cone diseases are progressive, causing a gradual decline in vision. Without timely intervention, there’s a risk of vision loss. Currently, definitive treatments for such genetic conditions are limited due to their direct connection to genes. However, Stem Cell Treatment presents a ray of hope by aiming to regenerate the affected photoreceptor cells, halting further deterioration, and promoting long-term eye health.

The approach involves employing Mesenchymal stem cells in one or two rounds of injections through a safe and highly effective route called “Retro-bulbar.” This method maximizes the regeneration of faulty or damaged retinal photoreceptor cells. Eye Stem Cell Center specializes not only in Rod and Cone dystrophies but also in treating conditions like Stargardt’s/Macular Dystrophy, diabetic retinopathy, and macular degeneration, among others since more than 12 years.

Diabetic retinopathy is a complication arising from high blood sugar levels, causing damage to blood vessels within the retina. Eye Stem Cell Center addresses this issue, emphasizing the importance of managing blood sugar levels to mitigate such complications. By intervening at the cellular level, the Centre aims to prevent or alleviate the detrimental effects of diabetic retinopathy.

The treatment protocols provided focus on regenerating photoreceptor cells, with an emphasis on personalized care based on the patient’s health status. Stem Cell Therapy offers a potential solution by harnessing the body’s regenerative capacity to restore vision and maintain ocular health over an extended period. Through a comprehensive approach and specialized protocols, the Centre endeavors to combat various retinal conditions, offering hope and improved quality of life for patients with vision-related ailments.

Eye Stem Cell Center offers promising prospects in addressing these conditions. This Stem Cell therapy aims to restore vision by regenerating the damaged photoreceptor cells associated with Rod and Cone diseases. By initiating this treatment, further degradation of these cells can be halted, contributing to the restoration of ocular health and promoting sustained regeneration of the eyes over an extended period.